The company's multi-year strategy involves the rollout of new products and upgrades to existing ones that further strengthen its position.
Biotech company 10x Genomics filed two lawsuits against rival Illumina in Delaware federal court on Tuesday, accusing ...
Illumina is rated a BUY as it drives growth with AI, multiomics, and strategic acquisitions. Click here to read my earnings ...
Press Trust of India on MSN
Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot
Illumina's up-and-coming constellation innovation delivers accuracy, speed, and ease of use in trial by GeneDx Constellation outperformed orthogonal methods in identifying select difficult-to-map ...
The company shared pilot data about its Constellation tech and released 5-Base, a product for jointly analyzing genetic and epigenetic data.
Genedx LLC partnered with Illumina Inc. to test whether Illumina's constellation map read technology could shed light on hard ...
Taiwan-based gene sequencing company Genomics BioSci & Tech has entered a strategic partnership with global sequencing leader Illumina to jointly promote gene sequencing and multi-omics technologies ...
Billionaire Elon Musk joined a growing campaign to cancel Netflix after the creator of a pro-transgender cartoon for children allegedly condemned activist Charlie Kirk following his death. The Netflix ...
America’s crippling strikes against Iran’s nuclear program in June have created a narrow window to avoid a strategic nightmare: namely, fighting China, Russia, and Iran all at once. To stop Russia ...
Illumina is launching a new informatics and artificial intelligence software business aimed at drug developers, with the goal of digesting large-scale DNA sequencing and multi-omics data. The ...
Cartoon Network has become one of the premier destinations on cable television for viewing some of the biggest original animated properties. Throughout its history, the Warner Bros-owned network has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results